Company Snapshot

Read it, Learn it and Do it for your investment Needs
Key Financial Ratios
Bafna Pharmaceuticals Ltd
Pharmaceuticals - Indian - Formulations
BSE Code: 532989 NSE Symbol: BAFNAPH P/E : 38.15
ISIN Demat: INE878I01022 Div & Yield %: 0 EPS : 4.25
Book Value: 35.85 Market Cap (Rs. Cr.): 383.59 Face Value : 10
ParticularsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debt-Equity Ratio0.320.310.250.220.17
Long Term Debt-Equity Ratio0.150.120.100.090.08
Current Ratio1.691.802.022.172.07
Fixed Assets1.421.571.261.020.93
Inventory5.055.885.434.775.31
Debtors3.413.524.127.009.14
Interest Cover Ratio3.334.216.7010.348.88
PBIDTM (%)9.599.6016.4616.0415.50
PBITM (%)6.246.3211.849.609.21
PBDTM (%)7.728.0914.6915.1214.46
CPM (%)7.728.1014.4515.1214.48
APATM (%)4.374.829.838.678.19
ROCE (%)5.826.299.365.776.66
RONW (%)4.985.748.865.776.52